Inactivated COVID-19 vaccine BBV152/COVAXIN effectively neutralizes recently emerged B 1.1.7 variant of SARS-CoV-2

Lignende værker

• Neutralization of B.1.1.28 P2 variant with sera of natural SARS-CoV-2 infection and recipients of inactivated COVID-19 vaccine Covaxin
  af: Sapkal, Gajanan, et al.
  Udgivet: (2021)
• Immunogenicity and protective efficacy of BBV152, whole virion inactivated SARS- CoV-2 vaccine candidates in the Syrian hamster model
  af: Mohandas, Sreelekshmy, et al.
  Udgivet: (2021)
• Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial
  af: Ella, Raches, et al.
  Udgivet: (2021)
• Immunogenicity and protective efficacy of inactivated SARS-CoV-2 vaccine candidate, BBV152 in rhesus macaques
  af: Yadav, Pragya D., et al.
  Udgivet: (2021)
• Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trial
  af: Ella, Raches, et al.
  Udgivet: (2021)